Community/Retail

Common issues that affect patient outcomes include economic stability, education access, health care access, social and community context, and neighborhood environment.

Results of the phase 3 VOYAGER PAD clinical trial show rivaroxaban (Xarelto; Janssen Pharmaceutical Companies) plus aspirin lowers severe vascular events in patients with peripheral arterial disease after lower-extremity revascularization.

Empagliflozin (Jardiance, Boehringer Ingelheim/Lilly) tablets are the first and only heart failure therapy to demonstrate a statistically significant risk reduction in cardiovascular death.

Session explores data from both the SCORED trial of sotagliflozin and the REVERSE-IT trial investigating bentracimab to reverse the antiplatelet effects of ticagrelor.

Health care professionals need to meet their patients at their health level and find a diet and medication regimen that works for them to best reduce the risk of cardiovascular events.

Pharmacy Times spoke with Craig Granowitz, MD, PhD, chief medical officer at Lexicon Pharmaceuticals, to learn more about sotagliflozin and new data being presented at the American College of Cardiology 2022 Scientific Sessions.

Pharmacy Times spoke with Orly Vardeny, PharmD, MS, a core investigator at the Center for Care Delivery and Outcomes Research in the US Department of Veterans Affairs, about pharmacists’ roles in managing pharmacotherapy disparities.

Lowering salt intake was not found to reduce visits to the emergency department, however, there were improvements in quality of life.

Milind Desai, MD, national principal investigator of the VALOR-HCM trial, discussed new results presented at the American College of Cardiology 2022 Scientific Sessions.

A just culture safety science framework can help prevent medication errors.

George MacKinnon, founding dean of the Medical College of Wisconsin School of Pharmacy and a professor there, discusses burnout in the pharmacy and how it can ultimately impact patients.

Technicians have become so much more essential in pharmacies and to patients than their titles imply.

Investigators followed men and women aged 20 to 40 years without pre-existing disease, and findings indicate that obesity and physical inactivity increase the impact of the disease.

In part 2 of the Pharmacy Times® Pharmacy Face-Off Gameshow™, pharmacy students from the University of the Sciences Philadelphia College of Pharmacy and the Rutgers University Ernest Mario School of Pharmacy entered a lightning round with clinical questions.

New CDC guidelines based on four decades of safety, immunogenicity, and efficacy data on the HBV vaccine, but with suboptimal coverage in the United States.

Ganciclovir ophthalmic gel (Zirgan) is a topical ophthalmic antiviral that is indicated for the treatment of acute herpetic keratitis (dendritic ulcers).

Calamine spray treats insect bites, rashes, minor skin irritations, and minor cuts.

Pharmacy managers can cultivate an innovative mindset amongst staff members by adopting an attitude that is welcoming to change.

How would you handle these patients' questions?

Deucravacitinib is a possible solution for patients with psoriasis who wish to have the convenience of an oral medication.

Vimala Raghavendran, MBA, head of the Pharmaceutical Supply Chain Center at US Pharmacopeia (USP), explains how pharmacists can get involved in USP’s Medicine Supply Vulnerability Insights Series assessing global pharmaceutical supply chain vulnerabilities.

Triumeq is a tablet containing 50 mg of dolutegravir, 600 mg of abacavir, and 300 mg of lamivudine.

This month's product news features PMS gummy vitamins, a prebiotic acne therapy, and apple cider vinegar supplements.

Golytely is indicated for cleansing of the colon in preparation for colonoscopy and barium enema X-ray examination in adults.

Purelax aids in the treatment of occasional constipation and irregularity.

Brought to you by the Sassy Pharmacist

They are also at greater risk of death than men when undergoing cardiac procedures, a new analysis shows.

The FDA has approved pilocarpine hydrochloride ophthalmic solution 1.25% (Vuity, Allergan, an AbbVie company) to treat presbyopia in adults.1